Description
Pain Management Conference
Saturday, January 25, 2025
Scratching the Surface: A Review of Pain Pathophysiology and
Pharmacology
8:00-9:30am
Satya Yaramati, PharmD, PGY2 Pain & Palliative Care Pharmacy Resident, UF Health Jacksonville
Upon completion of this activity, technicians will be able to:
Describe the various types of pain; Summarize the indications
and side effect profile of different pain agents; Recognize
opportunities for intervention regarding pain management therapy.
UAN: 0675-0000-25-001-L08-T
Recognizing the Danger Zone: Strategies and Considerations in Adjusting
Pain Management Treatment Regimens in Chronic Pain Management
9:30-11:00am
Robin Moorman Li, PharmD, BCACP, NBC-HWC, Assistant Director Jacksonville Campus, Clinical Associate Professor, University of Florida,
College of Pharmacy
Upon completion of this activity, technicians will be able to: Recognize a
comprehensive pain management plan; Identify reasons why commonly used
analgesic regimens must be adjusted due to patient related and agent related
variables; Calculate dose conversions of certain opioids; List important patient
education points on opioid conversions.
UAN: 675-0000-25-002-L08-T*
A Novel Approach: Preventing & Treating Chronic Pain Due to
Obesity in the Healthcare Setting
11:15-12:45pm
Matthew Hermenau, PharmD, CPT, NBC-HWC, Inpatient Pain Stewardship
Clinical Pharmacist, Jackson Memorial Hospital
Upon completion of this activity, technicians will be able to: Explain the
correlation between degenerative joint disease, obesity, and chronic pain in
the United States; Compare the current pitfalls of the healthcare model for
chronic pain due to obesity; Recognize non-pharmacologic ways to combat the
obesity crisis and subsequent chronic pain.
UAN: 0675-0000-25-003-L08-T
Managing Pain in Multiple Sclerosis
12:45-2:15pm
Lillian Smith, PharmD, MDA, CPh Associate Professor of Pharmacy Practice,
FAMU College of Pharmacy
Upon completion of this activity, technicians will be able to: Define
Multiple Sclerosis (MS); Provide an overview of the risk factors and symptoms
associated with MS; Compare and contrast between the primary, secondary,
and tertiary symptoms caused by multiple sclerosis; Categorize the four types
of multiple sclerosis; Outline both non-pharmacological and pharmacological
interventions currently available for the treatment of the disease.
UAN: 675-0000-25-004-L01-T*
Sunday, January 26, 2025
The Role of the Pharmacist in Palliative Care
8:00-9:30am
Katie Maples, PharmD, Pain and Palliative Care Coordinator and Opioid
Stewardship Pharmacist, UF Health Jacksonville
Upon completion of this activity, technicians will be able to: Define Palliative
Care; Discuss the importance of defining goals of care throughout the disease
process; Identify symptom management medications frequently used at the
end of life; Identify common misconceptions related to medication usage at
end of life.
UAN: 675-0000-25-006-L08-T
When Aging Isn’t So Fun: Pain Management, Polypharmacy and
Deprescribing in the Elderly
9:30-11:00am
Paige Broccio, PharmD, BCPS, Clinical Pharmacy Specialist, Pain Management and Palliative Care
Upon completion of this activity, technicians will be able to: Define
polypharmacy and the importance of deprescribing in the elderly; Differentiate
pharmacologic differences in the elderly population; Compare various pain
management options in the elderly.
UAN: 0675-0000-25-007-L08-T*
Overview of Buprenorphine
11:15-12:45pm
Taylor Bunn PharmD, PGY-1 Pharmacy Resident, UF Health Jacksonville
Upon completion of this activity, technicians will be able to:
Recognize the usual doses of buprenorphine; Assess areas of pharmacy
interventions; Evaluate the effects of pharmacist managed micro-induction.
UAN: 675-0000-25-008-L08-T*
Abnormal Urine Drug Screen: What’s Next?
12:45-2:15pm
Joseph Cammilleri, Pharm.D,. BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management, PGY2 Pain and Palliative Care Program Director, UF Clinical Assistant Professor, UF Health Jacksonville
Upon completion of this activity, technicians will be able to: Describe
common urine drug testing methods; Research strategies for managing
abnormal results; Outline a strategy for tapering off opioid medications;
Translate the importance of transition to buprenorphine. Upon completion of
this activity, technicians will be able to: Describe common urine drug testing
methods; Research strategies for managing abnormal results; Outline a strategy
for tapering off opioid medications; Translate the importance of transition to
buprenorphine.
UAN: 0675-0000-25-009-L08-T*
T = Technician CPE
